Engineering of Cell Derived-Nanovesicle as an Alternative to Exosome Therapy

Hye-Jeong Jang,Kyu-Sik Shim,Jinah Lee,Joo Hyeon Park,Seong-Jun Kang,Young Min Shin,Jung Bok Lee,Wooyeol Baek,Jeong-Kee Yoon
DOI: https://doi.org/10.1007/s13770-023-00610-4
2023-12-09
Tissue Engineering and Regenerative Medicine
Abstract:Exosomes, nano-sized vesicles ranging between 30 and 150 nm secreted by human cells, play a pivotal role in long-range intercellular communication and have attracted significant attention in the field of regenerative medicine. Nevertheless, their limited productivity and cost-effectiveness pose challenges for clinical applications. These issues have recently been addressed by cell-derived nanovesicles (CDNs), which are physically synthesized exosome-mimetic nanovesicles from parent cells, as a promising alternative to exosomes. CDNs exhibit structural, physical, and biological properties similar to exosomes, containing intracellular protein and genetic components encapsulated by the cell plasma membrane. These characteristics allow CDNs to be used as regenerative medicine and therapeutics on their own, or as a drug delivery system.
engineering, biomedical,cell & tissue engineering
What problem does this paper attempt to address?